Tapewire

NYSE · USD

LLY

ELI LILLY & Co

Export transactions ↓
Tapewire entity
2794
SEC CIK
0000059478
Parsed reports
2,757

Last 12 months

Inside the activity.

0 purchase rows · 240 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250200
Dec 202503
Jan 2026031
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 10, 2024 Filed Jul 11, 2024 20:00 UTC SaleCommon Stock 92,882 $939.95 $87,304,621.66
Disclosure

SEC source: 0001415889-24-019484 · form4-07112024_040702.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,992,459

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $939.50 to $940.49, inclusive.

Read SEC document
July 10, 2024 Filed Jul 11, 2024 20:00 UTC SaleCommon Stock 28,486 $939.11 $26,751,487.46
Disclosure

SEC source: 0001415889-24-019484 · form4-07112024_040702.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,085,341

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.50 to $939.49, inclusive.

Read SEC document
July 10, 2024 Filed Jul 11, 2024 20:00 UTC SaleCommon Stock 14,916 $938.03 $13,991,625.65
Disclosure

SEC source: 0001415889-24-019484 · form4-07112024_040702.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,113,827

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.50 to $938.47, inclusive.

Read SEC document
July 10, 2024 Filed Jul 11, 2024 20:00 UTC SaleCommon Stock 25,067 $936.90 $23,485,146.97
Disclosure

SEC source: 0001415889-24-019484 · form4-07112024_040702.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,128,743

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $936.50 to $937.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), and (9) to this Form 4.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 200 $928.25 $185,650.60
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 13

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,153,810

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.01 to $928.495, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 400 $927.30 $370,920.00
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 12

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,154,010

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.00 to $927.90, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 1,500 $926.23 $1,389,346.50
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 11

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,154,410

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.80 to $926.58, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 1,585 $924.71 $1,465,660.60
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 10

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,155,910

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $924.25 to $925.06, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 3,864 $923.70 $3,569,176.80
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,157,495

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $923.20 to $924.09, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 5,088 $922.61 $4,694,229.50
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,161,359

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $922.08 to $922.975, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 1,550 $921.45 $1,428,252.15
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,166,447

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $921.05 to $922.01, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 4,446 $920.37 $4,091,978.36
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,167,997

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $920.04 to $920.985, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 11,390 $919.41 $10,472,114.07
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,172,443

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $919.00 to $919.99, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 18,992 $918.35 $17,441,360.18
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,183,833

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $918.00 to $918.99, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 22,438 $917.47 $20,586,191.86
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,202,825

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $917.00 to $917.99, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 12,899 $916.49 $11,821,791.61
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,225,263

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $916.00 to $916.99, inclusive.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 20:00 UTC SaleCommon Stock 9,241 $915.62 $8,461,281.38
Disclosure

SEC source: 0001415889-24-019420 · form4-07092024_040702.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,238,162

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $915.00 to $915.985, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), and (13) to this Form 4.

Read SEC document
July 05, 2024 Filed Jul 8, 2024 20:00 UTC SaleCommon Stock 1,829 $916.25 $1,675,815.76
Disclosure

SEC source: 0001415889-24-019328 · form4-07082024_040701.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,247,403

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $916.00 to $916.49, inclusive.

Read SEC document
July 05, 2024 Filed Jul 8, 2024 20:00 UTC SaleCommon Stock 50,540 $915.14 $46,251,377.76
Disclosure

SEC source: 0001415889-24-019328 · form4-07082024_040701.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,249,232

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $915.00 to $915.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
July 03, 2024 Filed Jul 3, 2024 20:00 UTC SaleCommon Stock 400 $917.73 $367,090.40
Disclosure

SEC source: 0001415889-24-019154 · form4-07032024_040704.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,299,772

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $917.305 to $918.06, inclusive.

Read SEC document
July 03, 2024 Filed Jul 3, 2024 20:00 UTC SaleCommon Stock 400 $916.21 $366,485.20
Disclosure

SEC source: 0001415889-24-019154 · form4-07032024_040704.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,300,172

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $916.12 to $916.37, inclusive.

Read SEC document
July 03, 2024 Filed Jul 3, 2024 20:00 UTC SaleCommon Stock 8,048 $915.14 $7,365,078.91
Disclosure

SEC source: 0001415889-24-019154 · form4-07032024_040704.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,300,572

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $915.00 to $915.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2) and (3) to this Form 4.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:00 UTC SaleCommon Stock 4,800 $916.30 $4,398,216.00
Disclosure

SEC source: 0001415889-24-018842 · form4-07022024_040702.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,308,620

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $916.00 to $916.6475, inclusive.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:00 UTC SaleCommon Stock 53,949 $915.17 $49,372,560.28
Disclosure

SEC source: 0001415889-24-018842 · form4-07022024_040702.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,313,420

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $915.00 to $915.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
June 28, 2024 Filed Jul 1, 2024 20:00 UTC SaleCommon Stock 1,441 $915.02 $1,318,545.26
Disclosure

SEC source: 0001415889-24-018572 · form4-07012024_040701.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,367,369

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $915.00 to $915.185, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 853 $909.06 $775,427.33
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,368,810

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $909.00 to $909.10, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 5,610 $908.60 $5,097,257.22
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,369,663

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $908.00 to $908.995, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 6,763 $907.28 $6,135,921.11
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,375,273

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $907.00 to $907.90, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 4,806 $906.40 $4,356,158.40
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,382,036

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $906.00 to $906.99, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 4,019 $905.40 $3,638,806.62
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,386,842

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $905.00 to $905.94, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 46,359 $904.52 $41,932,549.96
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,390,861

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $904.00 to $904.92, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 62,127 $903.56 $56,135,658.50
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,437,220

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $903.00 to $903.99, inclusive.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 20:00 UTC SaleCommon Stock 57,563 $902.27 $51,937,483.14
Disclosure

SEC source: 0001415889-24-018204 · form4-06262024_040602.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,499,347

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $902.00 to $902.96, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4.

Read SEC document
June 24, 2024 Filed Jun 25, 2024 20:00 UTC SaleCommon Stock 1,200 $903.42 $1,084,101.60
Disclosure

SEC source: 0001415889-24-018119 · form4-06252024_040604.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,556,910

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $903.23 to $903.55, inclusive.

Read SEC document
June 24, 2024 Filed Jun 25, 2024 20:00 UTC SaleCommon Stock 16,029 $902.30 $14,462,966.70
Disclosure

SEC source: 0001415889-24-018119 · form4-06252024_040604.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,558,110

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $902.00 to $902.88, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
June 20, 2024 Filed Jun 21, 2024 20:00 UTC SaleCommon Stock 200 $904.25 $180,849.00
Disclosure

SEC source: 0001415889-24-017805 · form4-06212024_040602.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,574,139

Read SEC document
June 20, 2024 Filed Jun 21, 2024 20:00 UTC SaleCommon Stock 2,919 $903.50 $2,637,322.34
Disclosure

SEC source: 0001415889-24-017805 · form4-06212024_040602.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,574,339

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $903.025 to $903.945, inclusive.

Read SEC document
June 20, 2024 Filed Jun 21, 2024 20:00 UTC SaleCommon Stock 6,552 $902.25 $5,911,561.66
Disclosure

SEC source: 0001415889-24-017805 · form4-06212024_040602.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,577,258

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $902.00 to $902,72, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:17 UTC GrantCommon Stock 13 $885.01 $11,505.13
Disclosure

SEC source: 0000059478-24-000148 · wk-form4_1718741854.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,138

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:19 UTC GrantCommon Stock 11 $885.01 $9,735.11
Disclosure

SEC source: 0000059478-24-000150 · wk-form4_1718741947.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,503

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:20 UTC GrantCommon Stock 11 $885.01 $9,735.11
Disclosure

SEC source: 0000059478-24-000152 · wk-form4_1718742030.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,654

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:22 UTC GrantCommon Stock 17 $885.01 $15,045.17
Disclosure

SEC source: 0000059478-24-000154 · wk-form4_1718742118.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,738

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:23 UTC GrantCommon Stock 11 $885.01 $9,735.11
Disclosure

SEC source: 0000059478-24-000156 · wk-form4_1718742175.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,155

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 46 $892.14 $41,038.44
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 11

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,583,810

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 1,300 $891.54 $1,158,998.10
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 10

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,583,856

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $891.08 to $892.055, inclusive.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 6,121 $890.50 $5,450,768.86
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,585,156

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $890.00 to $890.99, inclusive.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 15,342 $889.36 $13,644,607.15
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,591,277

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $889.00 to $889.985, inclusive.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 18,293 $888.52 $16,253,641.48
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,606,619

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $888.00 to $888.995, inclusive.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 38,194 $887.47 $33,895,876.40
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,624,912

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $887.00 to $887.995, inclusive.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:00 UTC SaleCommon Stock 17,513 $886.60 $15,527,095.85
Disclosure

SEC source: 0001415889-24-017361 · form4-06182024_040602.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,663,106

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $886.00 to $886.995, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.